Home >> Gaucher's >> Gaucher's >> Food Equipment >> Technology & Media >>

Global Gaucher Disease Industry 2017 Market Research Report

Published: Feb-2017 | Format: PDF | QY Research | Number of pages: 141 | Code: MRS - 109238


The Global Gaucher Disease Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Gaucher Disease market. Also, a six-year historic analysis is provided for these markets. The global market for Gaucher Disease is expected to reach about 2045.70 M USD by 2021 from 1500.48 M USD in 2016, registering a Compounded Annual Growth Rate (CAGR) of 5.30% during the analysis period, 2016-2021.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. Whats more, the Gaucher Disease industry development trends and marketing channels are analyzed.

This report studies Gaucher Disease focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Sanofi
Shire
Actelion Pharma
Pfizer
ISU Pharm

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Gaucher Disease in these regions, from 2011 to 2016 (forecast), like
United States
Europe
Middle East
Other

Split by types, this report focuses on consumption, market share and growth rate of Gaucher Disease in each types, can be divided into
Enzyme replacement therapy
Substrate reduction therapy

Split by applications, this report focuses on consumption, market share and growth rate of Gaucher Disease in each application, can be divided into
Non-neuronopathic Gaucher disease
Neuronopathic Gaucher disease

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table of Contents

1 Industry Overview of Gaucher Disease1
1.1 Definition and Specifications of Gaucher Disease1
1.1.1 Definition of Gaucher Disease1
1.1.2 Specifications of Gaucher Disease2
1.2 Classification of Gaucher Disease2
1.2.1 Classification of Gaucher Disease by Therapy Types3
1.2.1.1 Enzyme Replacement Therapy3
1.2.1.2 Substrate Reduction Therapy4
1.2.2 Molecule Types6
1.2.2.1 Biologics6
1.2.2.2 Small Molecules6
1.3 Applications of Gaucher Disease6
1.4 Industry Chain Structure of Gaucher Disease10
1.5 Industry Overview and Major Regions Status of Gaucher Disease10
1.5.1 Industry Overview of Gaucher Disease10
1.5.2 Global Major Regions Status of Gaucher Disease11
1.6 Industry Policy Analysis of Gaucher Disease12
1.7 Industry News Analysis of Gaucher Disease14
2 Manufacturing Cost Structure Analysis of Gaucher Disease17
2.1 Raw Material Suppliers and Price Analysis of Gaucher Disease17
2.2 Equipment Suppliers Analysis of Gaucher Disease17
2.3 Labor Cost Analysis of Gaucher Disease18
2.4 Other Costs Analysis of Gaucher Disease22
2.5 Manufacturing Cost Structure Analysis of Gaucher Disease23
2.6 Manufacturing Process Analysis of Gaucher Disease23
3 Technical Data and Manufacturing Plants Analysis of Gaucher Disease24
3.1 Capacity and Commercial Production Date of Global Gaucher Disease Major Manufacturers in 201624
3.2 Manufacturing Plants Distribution of Global Gaucher Disease Major Manufacturers in 201524
3.3 R&D Status and Technology Source of Global Gaucher Disease Major Manufacturers in 201625
3.4 Raw Materials Sources Analysis of Global Gaucher Disease Major Manufacturers in 201626
4 Production Analysis of Gaucher Disease by Regions, Technology, and Applications27
4.1 Global Production of Gaucher Disease by Regions 2011-201627
4.2 Global Production of Gaucher Disease by Technology 2011-201631
4.3 Global Production of Gaucher Disease by Applications 2011-201636
4.4 Price Analysis of Global Gaucher Disease Key Manufacturers in 201642
4.5 USA Capacity, Production, Price, Cost and Revenue of Gaucher Disease 2011-201643
4.6 Europe Capacity, Production, Price, Cost and Revenue of Gaucher Disease 2011-201644
4.7 Middle East Capacity, Production, Price, Cost and Revenue of Gaucher Disease 2011-201644
4.8 USA Supply, Import, Export and Consumption of Gaucher Disease 2011-201645
4.9 Europe Supply, Import, Export and Consumption of Gaucher Disease 2011-201645
4.10 Middle East Supply, Import, Export and Consumption of Gaucher Disease 2011-201645
5 Consumption and Revenue Analysis of Gaucher Disease by Regions46
5.1 Global Consumption of Gaucher Disease by Regions 2011-201646
5.2 Global Revenue of Gaucher Disease by Regions 2011-201651
5.3 Global Price Analysis of Gaucher Disease Consumption by Regions 2011-201657
6 Analysis of Gaucher Disease Production, Supply, Consumption and Market Status 2011-201658
6.1 Capacity and Production of Gaucher Disease 2011-201658
6.2 Production Market Share Analysis of Gaucher Disease 2011-201661
6.3 Consumption Overview of Gaucher Disease 2011-201667
6.4 Supply, Consumption and Gap of Gaucher Disease 2011-201671
6.5 Import, Export and Consumption of Gaucher Disease 2011-201672
6.6 Cost, Price, Revenue and Gross Margin of Gaucher Disease 2011-201673
7 Major Manufacturers Analysis of Gaucher Disease76
7.1 Sanofi76
7.1.1 Company Profile76
7.1.2 Product Picture and Specifications77
7.1.2.1 Cerezyme? Picture and Specifications77
7.1.2.2 Cerdelga? Picture and Specifications79
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue80
7.1.4 Contact Information82
7.2 Shire82
7.2.1 Company Profile82
7.2.2 Product Picture and Specifications83
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue85
7.2.4 Contact Information87
7.3 Actelion Pharma87
7.3.1 Company Profile87
7.3.2 Product Picture and Specifications88
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue90
7.3.4 Contact Information92
7.4 Pfizer92
7.4.1 Company Profile92
7.4.2 Product Picture and Specifications93
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue95
7.4.4 Contact Information96
7.5 ISU Abxis96
7.5.1 Company Profile96
7.5.2 Product Picture and Specifications97
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue99
7.5.4 Contact Information101
7.6 JCR Pharmaceuticals101
7.6.1 Company Profile101
7.6.2 Contact Information102
7.7 Amicus Therapeutics102
7.7.1 Company Profile102
7.7.2 Contact Information103
8 Price and Gross Margin Analysis104
8.1 Analysis of Price, Supply and Consumption104
8.1.1 Price Analysis104
8.1.2 Supply Analysis105
8.2 Gross Margin Analysis105
8.3 Price Comparison by Regions106
8.4 Price Analysis of Different Gaucher Disease Product Types106
8.5 Market Share Analysis of Different Gaucher Disease Price Levels107
8.6 Gross Margin Analysis of Different Gaucher Disease Applications108
9 Marketing Trader or Distributor Analysis of Gaucher Disease109
9.1 Marketing Channels Status of Gaucher Disease109
9.2 Traders or Distributors with Contact Information of Gaucher Disease by Regions110
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Gaucher Disease111
9.4 Regional Import, Export Analysis of Gaucher Disease112
10 Development Trend of Gaucher Disease Industry 2016-2021F114
10.1 Capacity and Production Overview of Gaucher Disease 2016-2021F114
10.2 Production Market Share Analysis of Gaucher Disease 2016-2021F115
10.3 Consumption Overview of Gaucher Disease 2016-2021F117
10.4 Supply, Consumption, and Gap of Gaucher Disease 2016-2021F119
10.5 Cost, Price, Revenue and Gross Margin of Gaucher Disease 2016-2021F119
11 Industry Chain Analysis of Gaucher Disease120
11.1 Upstream Major Equipment Suppliers Analysis of Gaucher Disease120
11.2 Downstream Major Consumers Analysis of Gaucher Disease121
11.3 Supply Chain Relationship Analysis of Gaucher Disease122
12 New Project Investment Feasibility Analysis of Gaucher Disease123
12.1 New Project SWOT Analysis of Gaucher Disease123
12.2 New Project Investment Feasibility Analysis of Gaucher Disease123
13 Conclusion of the Global Gaucher Disease Industry 2016 Market Research Report125
14 Appendix126
Disclosure Section126
Research Methodology126
Data Source127
Disclaimer127
Author List129
Source of Data List129


List of Table

Figure Picture of Gaucher Disease1
Table Comparison of Main Models from Gaucher Disease Major Manufacturers2
Table Classification of Gaucher Disease2
Figure Global Production Market Share of Gaucher Disease by Types in 20163
Figure Enzyme Replacement Therapy Picture4
Table Major Manufacturers of Enzyme Replacement Therapy4
Figure Substrate Reduction Therapy Picture5
Table Major Manufacturers of Substrate Reduction Therapy5
Figure Biologics Picture6
Figure Small Molecules Picture6
Table Applications of Gaucher Disease6
Table Applications Comparison of Gaucher Disease7
Table Applications Comparison of Gaucher Disease7
Phenotypic Continuum of Application of Gaucher Disease8
Figure Global Consumption Volume Market Share of Gaucher Disease by Applications in 20169
Figure Industry Chain Structure of Gaucher Disease10
Table Global Gaucher Disease Major Manufacturers10
Figure Global Major Regions Gaucher Disease Revenue Market Share Development Status in 201511
Figure Global Major Regions Gaucher Disease Revenue Market Share Development Status in 201612
Table Industry Policy of Gaucher Disease12
Figure ERT Policy History of Gaucher Disease14
Table USA and EU Approved Time of Gaucher Disease Companies14
Table Industry News List of Gaucher Disease14
Figure Ingredient Analysis of Cerezyme17
Table Equipment Suppliers Analysis17
Figure United States Average Hourly Wages in Manufacturing (USD/Hour)18
Figure United States Average Weekly Hours18
Figure Euro Area Average Monthly Wage (EUR/Month)19
Figure China Minimum Monthly Wages (CNY/ Month)19
Figure Mexico Average Daily Wages (MXN/Day)20
Figure Indonesia Average Monthly Wages in Manufacturing (IDR THO/Month)20
Figure Vietnam Wages In Manufacturing (VND Thousand/Month)21
Figure Thailand Average Monthly Wages in Manufacturing (THB/Month)21
Table 2015 Global Electricity Price of Resident and Industry (USD/Kwh) by Country22
Figure Manufacturing Cost Structure Analysis of Gaucher Disease in 201623
Figure Manufacturing Process Analysis of Gaucher Disease23
Table Capacity (K Units) and Commercial Production Date of Global Gaucher Disease Major Manufacturers in 201624
Table Manufacturing Plants Distribution of Global Gaucher Disease Major Manufacturers in 201524
Table R&D Status and Technology Source of Global Gaucher Disease Major Manufacturers in 201625
Table Raw Materials Sources Analysis of Global Gaucher Disease Major Manufacturers in 201626
Table Global Production of Gaucher Disease by Regions 2011-2016 (K Unit)27
Figure Global Production Market Share of Gaucher Disease by Regions in 201127
Figure Global Production Market Share of Gaucher Disease by Regions in 201228
Figure Global Production Market Share of Gaucher Disease by Regions in 201328
Figure Global Production Market Share of Gaucher Disease by Regions in 201429
Figure Global Production Market Share of Gaucher Disease by Regions in 201530
Figure Global Production Market Share of Gaucher Disease by Regions in 201630
Table Global Production of Gaucher Disease by Technology 2011-2016 (K Unit)31
Figure Global Production Market Share of Gaucher Disease by Technology in 201131
Figure Global Production Market Share of Gaucher Disease by Technology in 201232
Figure Global Production Market Share of Gaucher Disease by Technology in 201333
Figure Global Production Market Share of Gaucher Disease by Technology in 201434
Figure Global Production Market Share of Gaucher Disease by Technology in 201535
Figure Global Production Market Share of Gaucher Disease by Technology in 201636
Table Global Production of Gaucher Disease by Applications 2011-2016 (K Unit)36
Figure Global Production Market Share of Gaucher Disease by Applications in 201137
Figure Global Production Market Share of Gaucher Disease by Applications in 201238
Figure Global Production Market Share of Gaucher Disease by Applications in 201339
Figure Global Production Market Share of Gaucher Disease by Applications in 201440
Figure Global Production Market Share of Gaucher Disease by Applications in 201541
Figure Global Production Market Share of Gaucher Disease by Applications in 201642
Table Price Comparison of Global Gaucher Disease Key Manufacturers 2011-2016 (USD/Unit)42
Figure Price Comparison of Global Gaucher Disease Key Manufacturers in 2016 (USD/Unit)43
Table USA Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit) and Revenue (M USD) of Gaucher Disease 2011-201643
Table Europe Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit) and Revenue (M USD) of Gaucher Disease 2011-201644
Table Middle East Capacity (K Unit), Production (K Unit), Price (USD/Unit), Cost (USD/Unit) and Revenue (M USD) of Gaucher Disease 2011-201644
Table USA Supply, Import, Export and Consumption of Gaucher Disease 2011-2016 (K Unit)45
Table Europe Supply, Import, Export and Consumption of Gaucher Disease 2011-2016 (K Unit)45
Table Middle East Supply, Import, Export and Consumption of Gaucher Disease 2011-2016 (K Unit)45
Table Global Consumption of Gaucher Disease by Regions 2011-2016 (K Unit)46
Figure Global Consumption of Gaucher Disease by Regions in 2011 (K Unit)46
Figure Global Consumption of Gaucher Disease by Regions in 2012 (K Unit)47
Figure Global Consumption of Gaucher Disease by Regions in 2013 (K Unit)48
Figure Global Consumption of Gaucher Disease by Regions in 2014 (K Unit)49
Figure Global Consumption of Gaucher Disease by Regions in 2015 (K Unit)50
Figure Global Consumption of Gaucher Disease by Regions in 2016 (K Unit)51
Table Global Revenue of Gaucher Disease by Regions 2011-2016 (M USD)51
Figure Global Revenue of Gaucher Disease by Regions in 2011 (M USD)52
Figure Global Revenue of Gaucher Disease by Regions in 2012 (M USD)53
Figure Global Revenue of Gaucher Disease by Regions in 2013 (M USD)54
Figure Global Revenue of Gaucher Disease by Regions in 2014 (M USD)55
Figure Global Revenue of Gaucher Disease by Regions in 2015 (M USD)56
Figure Global Revenue of Gaucher Disease by Regions in 2016 (M USD)57
Table Sale Price of Gaucher Disease by Regions 2011-2016 (USD/Unit)57
Table Global and Major Manufacturers Capacity Gaucher Disease 2011-2016 (K Unit)58
Table Global Capacity Market Share of Major Gaucher Disease Manufacturers 2011-201658
Table Global and Major Manufacturers Production of Gaucher Disease 2011-2016 (K Unit)58
Table Global Production Market Share of Major Gaucher Disease Manufacturers 2011-201659
Figure Global Capacity (K Unit), Production (K Unit) and Growth Rate of Gaucher Disease 2011-201659
Figure Global Capacity Utilization Rate of Gaucher Disease 2011-201660
Figure Global Production Market Share of Major Gaucher Disease Manufacturers in 201161
Figure Global Production Market Share of Major Gaucher Disease Manufacturers in 201262
Figure Global Production Market Share of Major Gaucher Disease Manufacturers in 201363
Figure Global Production Market Share of Major Gaucher Disease Manufacturers in 201464
Figure Global Production Market Share of Major Gaucher Disease Manufacturers in 201565
Figure Global Production Market Share of Major Gaucher Disease Manufacturers in 201666
Figure Global Consumption Volume (K Unit) and Growth Rate of Gaucher Disease 2011-201667
Figure Global Consumption Value (M USD) and Growth Rate of Gaucher Disease 2011-201668
Figure USA Consumption Volume (K Unit) and Growth Rate of Gaucher Disease 2011-201668
Figure USA Consumption Value (M USD) and Growth Rate of Gaucher Disease 2011-201669
Figure Europe Consumption Volume (K Unit) and Growth Rate of Gaucher Disease 2011-201669
Figure Europe Consumption Value (M USD) and Growth Rate of Gaucher Disease 2011-201670
Figure Middle East Consumption Volume (K Unit) and Growth Rate of Gaucher Disease 2011-201670
Figure Middle East Consumption Value (M USD) and Growth Rate of Gaucher Disease 2011-201671
Table Global Supply, Consumption and Gap of Gaucher Disease 2011-2016 (K Unit)71
Table USA Supply, Consumption and Gap of Gaucher Disease 2011-2016 (K Unit)71
Table Europe Supply, Consumption and Gap of Gaucher Disease 2011-2016 (K Unit)72
Table Middle East Supply, Consumption and Gap of Gaucher Disease 2011-2016 (K Unit)72
Table USA Supply, Import, Export and Consumption of Gaucher Disease 2011-2016 (K Unit)72
Table Europe Supply, Import, Export and Consumption of Gaucher Disease 2011-2016 (K Unit)72
Table Middle East Supply, Import, Export and Consumption of Gaucher Disease 2011-2016 (K Unit)73
Table Global and Major Manufacturers Revenue of Gaucher Disease 2011-2016 (M USD)73
Table Global Revenue Market Share of Major Gaucher Disease Manufacturers 2011-201673
Figure Global Revenue Market Share of Major Gaucher Disease Manufacturers in 201574
Figure Global Revenue Market Share of Major Gaucher Disease Manufacturers in 201675
Table Global Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Gaucher Disease 2011-201675
Table Sanofi Information List76
Figure Cerezyme? Picture and Specifications of Sanofi77
Figure Cerdelga? Picture and Specifications of Sanofi79
Table Gaucher Disease Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2011-201680
Figure Gaucher Disease Capacity (K Units), Production (K Units) and Growth Rate of Sanofi 2011-201681
Figure Gaucher Disease Production (K Units) and Global Market Share of Sanofi 2011-201681
Table Shire Information List82
Figure VPRIV? Picture and Specifications of Shire83
Figure Clinical Trial Program of VPRIV?85
Table Gaucher Disease Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Shire 2011-201685
Figure Gaucher Disease Capacity (K Units), Production (K Units) and Growth Rate of Shire 2011-201686
Figure Gaucher Disease Production (K Units) and Global Market Share of Shire 2011-201686
Table Actelion Pharma Information List87
Figure Zavesca? Picture and Specifications of Actelion Pharma88
Table Gaucher Disease Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Actelion Pharma 2011-201690
Figure Gaucher Disease Capacity (K Units), Production (K Units) and Growth Rate of Actelion Pharma 2011-201691
Figure Gaucher Disease Production (K Units) and Global Market Share of Actelion Pharma 2011-201691
Table Pfizer Information List92
Figure ELELYSO? Picture and Specifications of Pfizer93
Table Gaucher Disease Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2011-201695
Figure Gaucher Disease Capacity (K Units), Production (K Units) and Growth Rate of Pfizer 2011-201695
Figure Gaucher Disease Production (K Units) and Global Market Share of Pfizer 2011-201696
Table ISU Abxis Information List96
Figure Abcertin? Picture and Specifications of ISU Abxis97
Table Gaucher Disease Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ISU Abxis 2011-201699
Figure Gaucher Disease Capacity (K Units), Production (K Units) and Growth Rate of ISU Abxis 2011-2016100
Figure Gaucher Disease Production (K Units) and Global Market Share of ISU Abxis 2011-2016100
Table JCR Pharmaceuticals Information List101
Table Amicus Therapeutics Information List102
Table Consumption Price and Ex-factory Price (USD/Unit) Comparison 2011-2016104
Figure Consumption Price and Ex-factory Price (USD/Unit) Comparison 2011-2016104
Figure Supply and Consumption Comparison in 2016 (K Unit)105
Table Gross Margin of Global Regions 2011-2016105
Figure Consumption Price Comparison of Gaucher Disease by Regions 2011-2016 (USD/Unit)106
Table Price of Different Gaucher Disease Product Types (USD/Unit)106
Figure Production Market Share of Different Gaucher Disease Price Level in 2016 (USD/Unit)107
Figure Gross Margin of Different Gaucher Disease Applications 2016108
Figure Marketing Channels of Gaucher Disease109
Table Traders or Distributors with Contact Information of Gaucher Disease by Regions110
Figure Relationship between Ex-work Price and Consumption Price (without Import and Export)111
Figure Relationship between Ex-work Price and Consumption Price (Import and Export)112
Table Regional Import of Gaucher Disease (K Units)112
Table Regional Export of Gaucher Disease (K Units)112
Figure Global Capacity (K Unit), Production (K Unit) and Growth Rate of Gaucher Disease 2016-2021F114
Figure Global Capacity Utilization Rate of Gaucher Disease 2016-2021F115
Table Global Production of Gaucher Disease by Regions 2016-2021F (K Unit)115
Figure Global Production Market Share of Gaucher Disease by Regions in 2021116
Figure Global Consumption (K Unit) and Growth Rate of Gaucher Disease 2016-2021F117
Figure Global Consumption Volume and Growth Rate of Gaucher Disease 2016-2021F (K Unit)118
Figure Global Consumption Valueand Growth Rate of Gaucher Disease 2016-2021F (M USD)118
Table Global Supply, Consumption and Gap of Gaucher Disease 2016-2021F (K Unit)119
Table Global Production (K Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Gaucher Disease 2016-2021F119
Table Major Equipment Suppliers with Contact Information of Gaucher Disease120
Table Major Consumers with Contact Information of Gaucher Disease121
Figure Supply Chain Relationship Analysis of Gaucher Disease122
Table New Project SWOT Analysis of Gaucher Disease123
Table New Project Investment Feasibility Analysis of Gaucher Disease123

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2800 View Pricing